南模生物(688265.SH):股東海潤榮豐、康君寧元、張江集體簽署股份轉讓協議
格隆匯6月27日丨南模生物(688265.SH)公佈,公司收到股東海潤榮豐、康君寧元、張江集體的通知,出於資金需求的考慮,海潤榮豐、康君寧元、張江集體於2025年6月25日與海望合縱分別簽署了《關於上海南方模式生物科技股份有限公司之股份轉讓協議》。海潤榮豐擬通過協議轉讓的方式將其持有的4,650,318股公司股份以27.369元/股的價格轉讓給海望合縱,轉讓股份佔公司總股本的5.96%;康君寧元擬通過協議轉讓的方式將其持有的2,247,409股公司股份以27.369元/股的價格轉讓給海望合縱,轉讓股份佔公司總股本的2.88%;張江集體擬通過協議轉讓的方式將其持有的1,782,000股公司股份以27.369元/股的價格轉讓給海望合縱,轉讓股份佔公司總股本的2.29%。
海望合縱與持有公司2.77%股權的股東浦東新產業為一致行動人。
本次權益變動前,海潤榮豐持有公司股份4,650,318股,佔公司總股本的5.96%;康君寧元持有公司股份3,808,110股,佔公司總股本的4.88%;張江集體持有公司股份1,782,000股,佔公司總股本的2.29%;海望合縱未持有公司股份。本次權益變動後,海潤榮豐、張江集體將不再持有公司股份;康君寧元持有公司股份1,560,701股,佔公司總股本的2.00%;海望合縱持有公司股份8,679,727股,佔公司總股本的11.13%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.